Literature DB >> 12228193

Pediatric Hodgkin's therapy: time for a paradigm shift.

Melissa M Hudson.   

Abstract

Mesh：

Year:  2002        PMID： 12228193     DOI： 10.1200/JCO.2002.20.18.3755

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.

Authors:  Sharon M Castellino; Ann M Geiger; Ann C Mertens; Wendy M Leisenring; Janet A Tooze; Pam Goodman; Marilyn Stovall; Leslie L Robison; Melissa M Hudson
Journal:  Blood       Date:  2010-10-29       Impact factor: 22.113

Review 2.  18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's.

Authors:  Sue C Kaste; Scott C Howard; Elizabeth B McCarville; Matthew J Krasin; Philip G Kogos; Melissa M Hudson
Journal:  Pediatr Radiol       Date:  2004-11-16

3.  Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks.

Authors:  Jennifer M Yeh; Lisa Diller
Journal:  Blood       Date:  2012-07-23       Impact factor: 22.113

Review 4.  PET imaging in pediatric Hodgkin's lymphoma.

Authors:  Melissa M Hudson; Matthew J Krasin; Sue C Kaste
Journal:  Pediatr Radiol       Date:  2004-01-27

5.  Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study.

Authors:  Kevin C Oeffinger; Kayla L Stratton; Melissa M Hudson; Wendy M Leisenring; Tara O Henderson; Rebecca M Howell; Suzanne L Wolden; Louis S Constine; Lisa R Diller; Charles A Sklar; Paul C Nathan; Sharon M Castellino; Dana Barnea; Susan A Smith; Raymond J Hutchinson; Gregory T Armstrong; Leslie L Robison
Journal:  J Clin Oncol       Date:  2021-02-25       Impact factor: 50.717

Review 6.  The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?

Authors:  Jamie E Flerlage; Monika L Metzger; Nickhill Bhakta
Journal:  Blood       Date:  2018-06-12       Impact factor: 25.476
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.